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ALPHA-I-antitrypsin deficiency associated with 
n chronic obstructive airway disease was recog-
nized in 1963 by Laurell and Ericksson. I In 1969, 
. Sharp' described the first cases of alpha-l-antitryp-
sin-deficiency disease in children with cirrhosis. Since 
then, this ·inborn error has been recognized as one of 
the more common factors in cirrhosis of infancy and 
childhood,] including "neonatal hepatitis." 4 Alpha-t-
antitrypsin is a glycoprotein that accounts for a major 
portion of the alpha-l globulin fraction of the serum. S 
It is responsible for approximately 90 per cent of the 
antitrypsin activity' of the serum, and it also inhibits 
several other plasma enzymes, including plasmin,' 
elastase,' collagenase,' and chymotrypsin. 'o 
Cirrhosis de\;e1ops in about 15 per cent ·of patients 
with homozygous phenotype PiZZ (Pi = protease in-
hibitor), II and there have been a few recent reports of 
cirrhosis in heterozygous patients. 12•n There has been 
no effective, specific medical treatment for such 
patients. This report will examine the place of 
orthotopic liver transplantation in the treatment of 
seven white patients who had end-stage Ih'er disease 
due to alpha-I-antitrypsin deficiency. After transplan-
tation, the phenotypes of the recipients became those 
of the donors, and alpha- 'l--antitrypsin levels were 
restored to normal. Thus, the metabolic basis of the 
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discas(' was corrected for as long as the patients sur-
vh'cd the transplantation procedure. Three of the 
patients are still alive after t3, 21, and 36 months. TIle 
others died between 12 days and 28 months after 
transplantation. 
METHODS 
Liver replacements were performed in seven patients who had 
alpha.l.antitrypsin deficiency disease. One ofthese cases has been 
reported previously." Phenotypes for alpha.l.antitrypsin (Pi) were 
determined by means of acid·starch electrophoresis followed by 
crossed immunocle(:trophoresis. as described e1sewhere. u", The 
nomenclature recommended by the International Alpha-t-anti-
trypsin Pi Committee was used." The normal alpha· I-antitrypsin 
values were established by means of analysis of serum, from 22t3 
Red Cross donors in I..os Angeles. all with the phenotype MM. The 
range of 140 to 470 mg per 100 ml encompassed approximately two 
standard deviations from the mean. 
CASE REPORTS 
Case 1 
This case has been reported in detail previously." A 16-year.old 
girl with alpha-t-antitrypsin.deficiency lh'er disease had an oMho-
topic liver transplant in November. 1973. After transplantation her 
phenotype became MM, identical to the donor's. The graft func-
tioned well for 11,7 years but then deteriorated from chronic rejec-
tion during the next nine months.· Retransplantation was carried 
out in February, 1976. and again tht're was change to the donor 
phenotype, in this case MZ. She died of infection five weeks after 
the operation. 
Case 2 
A IS-year-old boy who had had a "neonatal hepatitis" was found 
to have a deficienc), of alpha-I.-antitrypsin and cirrhosis with 
progressive Ih'cr failure. Lh'cr transplantation was performed in 
November. 1976. After the operation pneumatosis c),stoides intes· 
tinalis and rectal bleeding de\·e1oped, necessitating a subtotal col-
ectomy. He was discharged in April, 1977. and remains well with 
normal liver function three years later. 
Case 3 
A 25-year.old man had been wdl until hi$ 17th year, when he 
had right-sided abdominal pain. At laparotomy, splenomegaly and 
cirrhosis (Laennec's) were diagnosed. In 1976, at 25 years of age, he 
had a second lh'er biopsy; the diagnosis of alpha.l·antitrypsin 
deficiency was established. Because of progressh'e hepatic failure, 
liver transplantation was carried out in December, 1976. Portal-
vein thrombosis was found, requiring phlebothrom~ctomy before 
an end-to-end portal-\'ein anastomosis could be attempted. After 
the operation he had progressh·e liver failure. and a second trans· 
plaination was performed 10 days later. The recipient pOMal vein 
was clotted. and the second graft was inserted without a pOMal in-
flow. The liver failure was not relieved, and he died two days after 
retransplantation. • 
Case 4 
A fi\'e-year-old girl had been found to have alpha.l.antitrypsin 
deficiency shortly aftl'r biMh. Hepatic transplantation was per-
formed in February, 1978, because of cirrhosis and liver failure. An 
unsuspected tumor consisting of primitive hepatoC)·tes without 
neoplastic stromal elements but with some features of hepatoblas-
toma was found. She has done well for 21 months and has normal 
liver function. 
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Cllse 5 
An CDighl-FD~ar-old boy had been found to ~ayDc ~fpha-f-flnlilrFDp­
sin-dcCidenc)' disease: in infancy. e~ had cirrhosIs, porlal h)11er-
tension, and recurrent bh:eding from esophilgl'al ,·arices. Ortho· 
topic Ih'cr transplantation "'as carried out in pcpte~ber! .1971:1. 
Initially, the Ih'er functioned well, but. he de\'doped per!tomus and 
required three explorator}' laparotomies. At Ci.rst, only Infected "~­
eitic fluid was found. but later a lefl subphremc abscess and multi-
ple Ih'cr abscesses developed. He diedin November, 1978, of sepsis. 
Case 6 
An II-)'ear-old boy had been found to ha\'e "neonellll hepaJitis" 
and was subsequently shown to have alpha-l-antitrypsin-deficienc), 
disease. Because of progressive cirrhosis and ascites, he had an 
orthotopic Ih'er transplant in October, 1978. He remains well with 
normal liver function \3 months after transplantation. 
Case 7 
A 9~I -year-old girl had been jaundiced shortly after birth and 
had progressive Iiyer disease. She was thought to have cf)'Ptogenic 
cirrhosis but was later shown to be heterozygous for alpha-I-anti-
trypsin deficiency. Transplantation was performed in January, 
1979. She did well for seven weeks after the operation and then died 
suddenly from a pulmonary embolus. 
RESULTS 
The cases are summarized in Table 1. None of the 
patients had clinical or laboratory evidence of ob-
structive lung disease. Liver failure was the reason for 
transplantation. After transplantation, good initial 
graft function was obtained in all but Case 3. The 
final liver function obtained in each recipientis shown 
in Table 1. Several serum alpha-I-antitrypsin deter-
minations were available for each patient; represen. 
tath'c individual values at specific times a~ shown in 
Tanle t. After transplantation, the Pi types of the 
recipicnts matched those of thc donors (Table 1). 
DISCUSSION 
I t is thought that the Pi alleles are inherited as co-
dominant alleles, with each allele responsible for the 
production of its own type of alpha-l-antitrypsin. 
Chromosome 2 probably carries the Pi aJlck. l ? PiM is 
the most common allele, with a frequency that varies 
geographically. In the United States its frequency 
seems to be 0_938 to 0.950. 11 In people of European 
ancestry the Z allele has an incidence ol 0.010 to 
0.016." 
Although alpha-I-antitrypsin deficiency is typically 
associated with either obstructive lung disease or 
childhood cirrhosis, it has been reported in associa-
tion with such diverse conditions as chronic pancrea-
titis,19 glomerulonephritis,20 rheumatoid arthritis,21 
subcutaneous and systemic panniculitis,u a <:onnec· 
tive-tissue disorder similar to the Ehlers-DanJos syn-
drome,2J and a multisystemic fibrosis. 2• 
The liver disease associated with alpha-I-antitryp-
sin deficiency usually presents as cholestatic jaundice 
within the first three or four months of Jire,25 and ac-
counts for approximately40 per 'cent of aU jaundice in 
the first. two months of life.2i The condition then 
usually abates until late childhood or early adoles-
cence, when cirrhosis and liver failure appear. The 
severity of the later disease does not appear related to 
the degree of jaundice in the early months. %7ln a small 
Table 1. Characteristics of Seven Patients Who Underwent liver Transplantation for Treatment of Liver Disease with Alpha-1-
Antitrypsin Deficiency. 
CASE )\;0. PHfSOHPfOF PHfSOT\'PE ALPHA-I· B,L/lll.,st hOTHRO., .. " Outc:o.cE 
RfCIPlf"'T OF DoNOR 
IEFOJ.£ T.",s-
AhllTa, ... PSIN LEVEL- TIMEt 
PLA:\"TATIOS 
I£FOkE A"U IEfOllE AFTER IIHORE A"fl 
qfKAkp~ nllss- TRANS- rR."ss· qKA~"p· TUNS-
PL.\!'Io'TA· miy~""· PLASTA- 'L4"TA- miAK~KA· PlA!'I."A-
nON TIOS TIOS TIOS TlOX TIOS 
''<If'Cdooml "'BI'" looml su 
ZZ MM (1st) .5.5 264 (.540)§ 27.0 0.6 21 12 Retransplantalion after 27 mo. 
MZ (2d) Died 5 wk later. 
2 ZZ MM 120 420 (ISO) 30.0 O.S 21 II Alive'" weill,... 
.fter transplantation. 
3 ZZ MM .55 140 (8) 41.0 25.0 19 20 Retransplantalion after 
10 days. Died 2 days 
tater .. 
4 ZZ MM 20 240 (70) 6.0 0.7 18 II Alive'" well 21 mo 
after transplaDtation. 
S ZZ MM .55 390 (18) 10.0 11.0 14 23 Died of sepsis 54 days 
after transplantation. 
6 ZZ MM 30 360 (10'" 4 . .5 0.3 12 11 Alive'" wdI13 mo 
36S) afler transplantation. 
7 MZ MM 40 190 (33) 60.0 1.0 30 10.S Died rrom pulmonary 
emboli 53 days after 
transplantation. 
·Ttl. Dorm.1 ran,. is 1.0 to 470 ma per 100 mI. 
'The norm.l value is I., ma per 100 m1. Values after transplantation "ere lhe last analyses in the patienls who died; Ihe \'Ilue, on: ~urrKnt for ""Iionl$ still alioc. 
*In controls. lh. lime ,·ari .. from 10.S to 12 seconds. 
tFilurcs in ""rrntheses denote nwnher oC days .Cler lim transplantalion that analysis ..... performed. 
, 
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number of patients resolution of the disease occurs.a 
Patients who do not develop the cholestatic pattern of 
disease are usually identified either when they present 
with hepatosplenomegaly or when a sibling is found to 
have the disease; without liver transplantation, they 
usually die in childhood or early adulthood from gas-
trointestinal bleeding or progressive liver failure. 
.Fagerhol and LaurelpQ were the first to determine 
the phenotypes of patients on the basis of antigen-
antibody crossed electrophoresis. With this test many 
polymorphic variants have been identified. The im-
portant variant from the clinical standpoint is the 
homozygote PiZZ, in whom the level of alpha-I-anti-
trypsin is 1 to 15 per cent of normal. With the PiNull 
phenotype that was discovered by Talamo et alK~ 
there is virtually no measurable alpha-l-antitrypsin, 
and there is an association with liver disease. The 
serum level of alpha-l-antitrypsin is less reduced with 
the mi~fw phenotype, and the clinical implications are 
less ominous. 
The pathophysiology of alpha-I-antitrypsin disease 
is not understood, but much evidence points to the 
role of the liver in influencing serum levels of the alpha 
protein. The characteristic histologic feature of the 
liver of patients with the Z alJele is a rounded cyto-
plasmic inclusion body, which is diastase resistant· 
and positive for the periodic acid-Schiff stain. The in-
clusion body is found near the rough endoplasmic re-
ticulum and can be shown to be alpha-l-antitrypsin 
by means of immunochemical methods.) \Vhat causes 
retention of this material in the liver is not known, but 
the explanation is almost certainly related to an ab-
n.ormal glycoprotein portion of the alpha-I-antitryp-
S10 molecule. Jt Early reports suggested that this ab-
normality in the glycoprotein '\1as simply a deficiency 
of sialic acid,'2 but more recently it has been recog-
nized that there is also an absence of galactose, an ap-
preciable decrease in N-acetylglycosamine, and an 
almost twofold increase in mannose residues." 
It has been suggested that such biochemical abnor-
malities interfere with the transport of alpha-I-anti-
trypsin into the bloodstream from the interior of the 
hepatocyte where it is synthesized. Some of this ab-
normal alpha-I-antitrypsin could diffuse passively 
into the bloodstream, accounting for the fact that even 
in the deficient state alpha-I-antitrypsin is not totally 
absent from serum. 
If the disease is primarily a failure in the transport 
of an abnormal protein, the nature of the enzymes 
responsible for the defective synthesis is unknown. 
Furthermore, the variability of clinical manifestations 
is perplexing. All persons with the Z allele accumu-
late alpha-t-antitrypsin in their hepatocytes, but ap-
parently not all develop liver disease even with the 
PiZZ state, and hepatic complications are less com-
mon in persons with the single-Z-allele states PiMZH 
and PiSZ. ,. Our heterozygous patient (Case 7) had 
very low le\'els of alpha-I-antitrypsin before trans-
plantation (Table 1); her clinical course and liver his-
topathology were entirely consistent with the disease. 
Although the precise pathophysiology of the dis-
ease has not been elucidated, the crucial role of the 
liver is well demonstrated by the data presented here. 
h has been shown previously in single-case reports 
both by us" and by Sharp)! that the phenotype of the 
recipient becomes that of the donor; this more exten-
sive series confirms that such a change occurs. Fur-
thermore, data from prolonged follow-up are avail-
able on three patients who are still alive, and after 
periods of up to three years there has been no evidence 
of reversion to the original phenotype or of a--eiminu~ 
tion in the serum levels of alpha- t -a ntitrypsin. It 
seems, therefore, that although the manifestations of 
the disease are many and variable, the fundamental 
defect lies within the liver and can be corrected by 
means of liver transplantation. It remains to be shown 
that patients who have successful liver transplants are 
immune to the development of other complications of 
the disease, such as lung disease, but to date no other 
complications have been seen. 
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